Results 31 to 40 of about 58,715 (292)

Results of using L-ornitin-L-aspartate in the treatment of hepatic encephalopathy in liver transplantation

open access: yesТрансплантология (Москва), 2021
The aim was to study the results of using various treatment regimens for hepatic encephalopathy for patients with liver cirrhosis before and after liver transplantation and the effect on the incidence and severity of hepatic encephalopathy in the ...
S. E. Voskanyan   +12 more
doaj   +1 more source

Minimal hepatic encephalopathy – diagnosis and treatment

open access: yesGastroenterology Review, 2021
Hepatic encephalopathy is a dysfunction of the central nervous system caused by chronic and acute liver disease. It presents a wide spectrum of symptoms from undetectable in a standard clinical examination to hepatic coma.
Wojciech Pisarek
doaj   +1 more source

RIFAXIMIN EFFECTIVENESS IN PREVENTING THE RECURRENCE OF HEPATIC ENCEPHALOPATHY AMONG PATIENTS WITH LIVER CIRRHOSIS

open access: yesPakistan Armed Forces Medical Journal, 2021
Objective: To determine the effectiveness of rifaximin in reducing the frequency of recurrence of hepatic encephalopathy among patients with liver cirrhosis. Study Design: Descriptive case series.
Muhammad Zulqurnain Saleem   +3 more
doaj   +1 more source

A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study

open access: yes, 2022
Liver Transplantation, EarlyView.
Andrew J. Groff   +5 more
wiley   +1 more source

Assessment of the Awareness and Self- Efficacy of Patients with Hepatic Encephalopathy Regarding Health Condition. [PDF]

open access: yesHelwan International Journal for Nursing Research and Practice
Background: Hepatic encephalopathy is a reversible syndrome observed in patients with advanced liver dysfunction. So, awareness and self-efficacy to patients are important for understanding psychological, cognitive and physical function. Aim of the study:
Hossam Hamdy
doaj   +1 more source

Assessment of Serum Biochemical Changes in Hepatic Encephalopathy

open access: yesPakistan Armed Forces Medical Journal, 2022
Objective: To analyze the association of various biochemical changes with different grades of hepatic encephalopathy among patients of hepatitis C-related decompensated liver disease presenting at Pak Emirates Military Hospital. Rawalpindi, Pakistan.
Amna Rauf, Sidra Rauf
doaj   +1 more source

Detection of hepatic encephalopathy [PDF]

open access: yesPostgraduate Medical Journal, 1986
Summary The most sensitive index of hepatic encephalopathy in 29 patients following a porta-caval shunt appeared to be the assessment of a close relative who had known the patient pre-operatively. They noticed that 19 of the 20 patients were mentally slower; 11 were markedly aggressive and 8 had become placid and uncaring about family ...
B G, Gazzard, H, Price, A M, Dawson
openaire   +2 more sources

Heretical thoughts into Hepatic Encephalopathy [PDF]

open access: yes, 2022
Clinical progress in the development of new diagnostic modalities and therapeutic strategies for the management of patients with hepatic encephalopathy has lagged behind the vast knowledge that has been generated from basic studies.
Rose, Christopher F   +2 more
core   +1 more source

Pathomechanisms in hepatic encephalopathy

open access: yesBiological Chemistry, 2021
Abstract Hepatic encephalopathy (HE) is a frequent neuropsychiatric complication in patients with acute or chronic liver failure. Symptoms of HE in particular include disturbances of sensory and motor functions and cognition. HE is triggered by heterogeneous factors such as ammonia being a main toxin, benzodiazepines, proinflammatory ...
Dieter Häussinger   +3 more
openaire   +2 more sources

Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic Scores. [PDF]

open access: yesLiver Int
ABSTRACT Background and Aims The role of transjugular intrahepatic portosystemic shunt (TIPS) in older adults remains controversial because of limited risk‐stratification tools. We aimed to assess whether sarcopenia and myosteatosis are independently associated with post‐TIPS mortality and overt hepatic encephalopathy (OHE) in patients aged ≥ 70 years,
Saltini D   +25 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy